[1]
P. Bar, S. Galiniak, D. Bartusik-Aebisher, R. Filip, and D. Aebisher, “Infliximab in therapy of inflammatory bowels diseases”, Eur J Clin Exp Med, vol. 17, no. 1, pp. 79–82, Mar. 2019.